{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:20:56Z","timestamp":1794230456093,"version":"4.9.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41582-019-0244-7","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T08:04:24Z","timestamp":1568016264000},"page":"565-581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3198,"title":["Ageing as a risk factor for neurodegenerative disease"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1778-1176","authenticated-orcid":false,"given":"Yujun","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Babbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-4911","authenticated-orcid":false,"given":"Steen G.","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Croteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-6429","authenticated-orcid":false,"given":"Vilhelm A.","family":"Bohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"244_CR1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.18632\/aging.100053","volume":"1","author":"MR Rose","year":"2009","unstructured":"Rose, M. R. Adaptation, aging, and genomic information. Aging 1, 444\u2013450 (2009).","journal-title":"Aging (Albany NY)"},{"key":"244_CR2","first-page":"7","volume":"68","author":"JJ Carmona","year":"2016","unstructured":"Carmona, J. J. & Michan, S. Biology of healthy aging and longevity. Rev. Invest. Clin. 68, 7\u201316 (2016).","journal-title":"Rev. Invest. Clin."},{"key":"244_CR3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","volume":"14","author":"Alzheimer\u2019s Association","year":"2018","unstructured":"Alzheimer\u2019s Association. 2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 14, 367\u2013429 (2018).","journal-title":"Alzheimers Dement"},{"key":"244_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180\u2013186 (2016).","journal-title":"Nature"},{"key":"244_CR5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnen\/nlw002","volume":"75","author":"A Elobeid","year":"2016","unstructured":"Elobeid, A., Libard, S., Leino, M., Popova, S. N. & Alafuzoff, I. Altered proteins in the aging brain. J.\u00a0Neuropathol. Exp. Neurol. 75, 316\u2013325 (2016).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"244_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaneurol.2013.4544","volume":"71","author":"DC Dean 3rd","year":"2014","unstructured":"Dean, D. C., 3rd et al. Brain differences in infants at\u00a0differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study. JAMA Neurol. 71, 11\u201322 (2014).","journal-title":"JAMA Neurol"},{"key":"244_CR7","first-page":"587","volume":"17","author":"AT Schaefers","year":"2016","unstructured":"Schaefers, A. T. & Teuchert-Noodt, G. Developmental neuroplasticity and the origin of neurodegenerative diseases. World J. Biol. Psychiatry 17, 587\u2013599 (2016).","journal-title":"World J. Biol. Psychiatry"},{"key":"244_CR8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum, R. L. & Ellis, C. E. Alzheimer\u2019s disease and Parkinson\u2019s disease. N. Engl. J. Med. 348, 1356\u20131364 (2003).","journal-title":"N. Engl. J. Med."},{"key":"244_CR9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.55.2.198","volume":"55","author":"LX Hy","year":"2000","unstructured":"Hy, L. X. & Keller, D. M. Prevalence of AD among whites: a summary by levels of severity. Neurology 55, 198\u2013204 (2000).","journal-title":"Neurology"},{"key":"244_CR10","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017).","journal-title":"Nat Rev Dis Primers"},{"key":"244_CR11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.15585\/mmwr.mm6707a3","volume":"67","author":"P Mehta","year":"2018","unstructured":"Mehta, P. et al. Prevalence of amyotrophic lateral sclerosis \u2013 United States, 2014. MMWR Morb. Mortal. Wkly. Rep. 67, 216\u2013218 (2018).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"244_CR12","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson, J. L. et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141, 2181\u20132193 (2018).","journal-title":"Brain"},{"key":"244_CR13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194\u20131217 (2013).","journal-title":"Cell"},{"key":"244_CR14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nrn4020","volume":"16","author":"HM Chow","year":"2015","unstructured":"Chow, H. M. & Herrup, K. Genomic integrity and the ageing brain. Nat. Rev. Neurosci. 16, 672\u2013684 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"244_CR15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuron.2014.06.034","volume":"83","author":"R Madabhushi","year":"2014","unstructured":"Madabhushi, R., Pan, L. & Tsai, L. H. DNA damage and its links to neurodegeneration. Neuron 83, 266\u2013282 (2014).","journal-title":"Neuron"},{"key":"244_CR16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pneurobio.2011.04.013","volume":"94","author":"DK Jeppesen","year":"2011","unstructured":"Jeppesen, D. K., Bohr, V. A. & Stevnsner, T. DNA repair deficiency in neurodegeneration. Prog. Neurobiol. 94, 166\u2013200 (2011).","journal-title":"Prog. Neurobiol."},{"key":"244_CR17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/ijms16010193","volume":"16","author":"R Thanan","year":"2015","unstructured":"Thanan, R. et al. Oxidative stress and its significant roles in neurodegenerative diseases and cancer. Int. J. Mol. Sci. 16, 193\u2013217 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"244_CR18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/nn.3537","volume":"16","author":"PJ McKinnon","year":"2013","unstructured":"McKinnon, P. J. Maintaining genome stability in the nervous system. Nat. Neurosci. 16, 1523\u20131529 (2013).","journal-title":"Nat. Neurosci."},{"key":"244_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgn250","volume":"30","author":"S Maynard","year":"2009","unstructured":"Maynard, S., Schurman, S. H., Harboe, C., de Souza-Pinto, N. C. & Bohr, V. A. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 30, 2\u201310 (2009).","journal-title":"Carcinogenesis"},{"key":"244_CR20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.18632\/oncotarget.2705","volume":"6","author":"G Tell","year":"2015","unstructured":"Tell, G. & Demple, B. Base excision DNA repair and cancer. Oncotarget 6, 584\u2013585 (2015).","journal-title":"Oncotarget"},{"key":"244_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrfmmm.2014.12.011","volume":"776","author":"GS Leandro","year":"2015","unstructured":"Leandro, G. S., Sykora, P. & Bohr, V. A. The impact of base excision DNA repair in age-related neurodegenerative diseases. Mutat. Res. 776, 31\u201339 (2015).","journal-title":"Mutat. Res."},{"key":"244_CR22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.dnarep.2015.04.029","volume":"32","author":"M Akbari","year":"2015","unstructured":"Akbari, M., Morevati, M., Croteau, D. & Bohr, V. A. The role of DNA base excision repair in brain homeostasis and disease. DNA Repair 32, 172\u2013179 (2015).","journal-title":"DNA Repair (Amst)"},{"key":"244_CR23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.molmed.2017.08.001","volume":"23","author":"EF Fang","year":"2017","unstructured":"Fang, E. F. et al. NAD(+) in aging: molecular mechanisms and translational implications. Trends\u00a0Mol. Med. 23, 899\u2013916 (2017).","journal-title":"Trends Mol. Med."},{"key":"244_CR24","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1515\/cclm-2017-0870","volume":"56","author":"M Herrmann","year":"2018","unstructured":"Herrmann, M., Pusceddu, I., Marz, W. & Herrmann, W. Telomere biology and age-related diseases. Clin.\u00a0Chem. Lab. Med. 56, 1210\u20131222 (2018).","journal-title":"Clin. Chem. Lab. Med."},{"key":"244_CR25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tins.2014.02.010","volume":"37","author":"E Eitan","year":"2014","unstructured":"Eitan, E., Hutchison, E. R. & Mattson, M. P. Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci. 37, 256\u2013263 (2014).","journal-title":"Trends Neurosci."},{"key":"244_CR26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.mad.2013.08.005","volume":"134","author":"MA Bradley-Whitman","year":"2013","unstructured":"Bradley-Whitman, M. A. & Lovell, M. A. Epigenetic changes in the progression of Alzheimer\u2019s disease. Mech. Ageing Dev. 134, 486\u2013495 (2013).","journal-title":"Mech. Ageing Dev."},{"key":"244_CR27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn.2017.46","volume":"18","author":"JY Hwang","year":"2017","unstructured":"Hwang, J. Y., Aromolaran, K. A. & Zukin, R. S. The emerging field of epigenetics in neurodegeneration and neuroprotection. Nat. Rev. Neurosci. 18, 347\u2013361 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"244_CR28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbamcr.2013.03.012","volume":"1843","author":"K Tanaka","year":"2014","unstructured":"Tanaka, K. & Matsuda, N. Proteostasis and neurodegeneration: the roles of proteasomal degradation and autophagy. Biochim. Biophys. Acta 1843, 197\u2013204 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"244_CR29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri, A. & Beal, M. F. Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther. 342, 619\u2013630 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"244_CR30","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbabio.2015.05.015","volume":"1847","author":"MJ Keogh","year":"2015","unstructured":"Keogh, M. J. & Chinnery, P. F. Mitochondrial DNA mutations in neurodegeneration. Biochim. Biophys. Acta 1847, 1401\u20131411 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"244_CR31","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene, J. C. et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl Acad. Sci. USA 100, 4078\u20134083 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"244_CR32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M. & Youle, R. J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85, 257\u2013273 (2015).","journal-title":"Neuron"},{"key":"244_CR33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","volume":"561","author":"DA Sliter","year":"2018","unstructured":"Sliter, D. A. et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 561, 258\u2013262 (2018).","journal-title":"Nature"},{"key":"244_CR34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuint.2017.02.007","volume":"109","author":"EM Fivenson","year":"2017","unstructured":"Fivenson, E. M. et al. Mitophagy in neurodegeneration and aging. Neurochem. Int. 109, 202\u2013209 (2017).","journal-title":"Neurochem. Int."},{"key":"244_CR35","doi-asserted-by":"crossref","DOI":"10.1038\/srep44373","volume":"7","author":"B Koentjoro","year":"2017","unstructured":"Koentjoro, B., Park, J. S. & Sue, C. M. Nix restores mitophagy and mitochondrial function to protect against PINK1\/parkin-related Parkinson\u2019s disease. Sci. Rep. 7, 44373 (2017).","journal-title":"Sci. Rep."},{"key":"244_CR36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fncel.2018.00092","volume":"12","author":"A Di Rita","year":"2018","unstructured":"Di Rita, A. et al. AMBRA1-mediated mitophagy counteracts oxidative stress and apoptosis induced by neurotoxicity in human neuroblastoma SH-SY5Y cells. Front. Cell. Neurosci. 12, 92 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"244_CR37","volume":"3","author":"J Yun","year":"2014","unstructured":"Yun, J. et al. MUL1 acts in parallel to the PINK1\/parkin pathway in regulating mitofusin and compensates for loss of PINK1\/parkin. Elife 3, e01958 (2014).","journal-title":"Elife"},{"key":"244_CR38","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1242\/jcs.075119","volume":"123","author":"CM Haynes","year":"2010","unstructured":"Haynes, C. M. & Ron, D. The mitochondrial UPR \u2013 protecting organelle protein homeostasis. J. Cell Sci. 123, 3849\u20133855 (2010).","journal-title":"J. Cell Sci."},{"key":"244_CR39","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0014-4827(65)90211-9","volume":"37","author":"L Hayflick","year":"1965","unstructured":"Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614\u2013636 (1965).","journal-title":"Exp. Cell Res."},{"key":"244_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.physiol.67.040403.103635","volume":"67","author":"D Kultz","year":"2005","unstructured":"Kultz, D. Molecular and evolutionary basis of the cellular stress response. Annu. Rev. Physiol. 67, 225\u2013257 (2005).","journal-title":"Annu. Rev. Physiol."},{"key":"244_CR41","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1101\/gad.1971610","volume":"24","author":"T Kuilman","year":"2010","unstructured":"Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463\u20132479 (2010).","journal-title":"Genes Dev."},{"key":"244_CR42","first-page":"155","volume":"1865","author":"N Loaiza","year":"2016","unstructured":"Loaiza, N. & Demaria, M. Cellular senescence and tumor promotion: is aging the key? Biochim. Biophys. Acta 1865, 155\u2013167 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"244_CR43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99\u2013118 (2010).","journal-title":"Annu. Rev. Pathol."},{"key":"244_CR44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2015.11.011","volume":"23","author":"CD Wiley","year":"2016","unstructured":"Wiley, C. D. et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell\u00a0Metab. 23, 303\u2013314 (2016).","journal-title":"Cell Metab."},{"key":"244_CR45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41556-019-0287-4","volume":"21","author":"T Nacarelli","year":"2019","unstructured":"Nacarelli, T. et al. NAD(+) metabolism governs the proinflammatory senescence-associated secretome. Nat. Cell Biol. 21, 397\u2013407 (2019).","journal-title":"Nat. Cell Biol."},{"key":"244_CR46","doi-asserted-by":"publisher","unstructured":"Maynard, S., Fang, E. F., Scheibye-Knudsen, M., Croteau, D. L. & Bohr, V. A. DNA damage, DNA repair, aging, and neurodegeneration. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a025130 (2015).","DOI":"10.1101\/cshperspect.a025130"},{"key":"244_CR47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32708-4","volume":"8","author":"E Barrio-Alonso","year":"2018","unstructured":"Barrio-Alonso, E., Hernandez-Vivanco, A., Walton, C. C., Perea, G. & Frade, J. M. Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons. Sci. Rep. 8, 14316 (2018).","journal-title":"Sci. Rep."},{"key":"244_CR48","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.3233\/JAD-161221","volume":"60","author":"E Fielder","year":"2017","unstructured":"Fielder, E., von Zglinicki, T. & Jurk, D. The DNA damage response in neurons: die by apoptosis or survive in a senescence-like state? J. Alzheimers Dis. 60, S107\u2013S131 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"244_CR49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1474-9726.2012.00870.x","volume":"11","author":"D Jurk","year":"2012","unstructured":"Jurk, D. et al. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11, 996\u20131004 (2012).","journal-title":"Aging Cell"},{"key":"244_CR50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004511","volume":"10","author":"A Vaidya","year":"2014","unstructured":"Vaidya, A. et al. Knock-in reporter mice demonstrate that DNA repair by non-homologous end joining declines with age. PLoS Genet. 10, e1004511 (2014).","journal-title":"PLoS Genet."},{"key":"244_CR51","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.1205407","volume":"332","author":"M Narita","year":"2011","unstructured":"Narita, M. et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332, 966\u2013970 (2011).","journal-title":"Science"},{"key":"244_CR52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4161\/auto.23922","volume":"9","author":"DA Gewirtz","year":"2013","unstructured":"Gewirtz, D. A. Autophagy and senescence: a\u00a0partnership in search of definition. Autophagy 9, 808\u2013812 (2013).","journal-title":"Autophagy"},{"key":"244_CR53","volume":"6","author":"HT Kang","year":"2011","unstructured":"Kang, H. T., Lee, K. B., Kim, S. Y., Choi, H. R. & Park, S. C. Autophagy impairment induces premature senescence in primary human fibroblasts. PLoS One 6, e23367 (2011).","journal-title":"PLoS One"},{"key":"244_CR54","doi-asserted-by":"crossref","first-page":"aaa5612","DOI":"10.1126\/science.aaa5612","volume":"349","author":"C Kang","year":"2015","unstructured":"Kang, C. et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 349, aaa5612 (2015).","journal-title":"Science"},{"key":"244_CR55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fgene.2016.00013","volume":"7","author":"N Bhatia-Dey","year":"2016","unstructured":"Bhatia-Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E. O. & Csoka, A. B. Cellular senescence as the causal nexus of aging. Front. Genet. 7, 13 (2016).","journal-title":"Front Genet"},{"key":"244_CR56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1172539","volume":"328","author":"L Fontana","year":"2010","unstructured":"Fontana, L., Partridge, L. & Longo, V. D. Extending healthy life span \u2013 from yeast to humans. Science 328, 321\u2013326 (2010).","journal-title":"Science"},{"key":"244_CR57","first-page":"109","volume":"5","author":"M Babbar","year":"2013","unstructured":"Babbar, M. & Sheikh, M. S. Metabolic stress and disorders related to alterations in mitochondrial fission or fusion. Mol. Cell. Pharmacol. 5, 109\u2013133 (2013).","journal-title":"Mol. Cell. Pharmacol."},{"key":"244_CR58","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nm.3651","volume":"20","author":"J Oh","year":"2014","unstructured":"Oh, J., Lee, Y. D. & Wagers, A. J. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat. Med. 20, 870\u2013880 (2014).","journal-title":"Nat. Med."},{"key":"244_CR59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nm.3569","volume":"20","author":"SA Villeda","year":"2014","unstructured":"Villeda, S. A. et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 20, 659\u2013663 (2014).","journal-title":"Nat. Med."},{"key":"244_CR60","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imm.12134","volume":"141","author":"S Amor","year":"2014","unstructured":"Amor, S. & Woodroofe, M. N. Innate and adaptive immune responses in neurodegeneration and repair. Immunology 141, 287\u2013291 (2014).","journal-title":"Immunology"},{"key":"244_CR61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/wsbm.1187","volume":"5","author":"F He","year":"2013","unstructured":"He, F. & Balling, R. The role of regulatory T cells in neurodegenerative diseases. Wiley Interdiscip. Rev. Syst. Biol. Med. 5, 153\u2013180 (2013).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"244_CR62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-018-0284-2","volume":"13","author":"W Cao","year":"2018","unstructured":"Cao, W. & Zheng, H. Peripheral immune system in aging and Alzheimer\u2019s disease. Mol. Neurodegener. 13, 51 (2018).","journal-title":"Mol. Neurodegener."},{"key":"244_CR63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4933-3-12","volume":"3","author":"S Giunta","year":"2006","unstructured":"Giunta, S. Is inflammaging an auto[innate]immunity subclinical syndrome? Immun. Ageing 3, 12 (2006).","journal-title":"Immun. Ageing"},{"key":"244_CR64","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.arr.2015.02.001","volume":"21","author":"A Currais","year":"2015","unstructured":"Currais, A. Ageing and inflammation \u2013 a central role for mitochondria in brain health and disease. Ageing Res. Rev. 21, 30\u201342 (2015).","journal-title":"Ageing Res Rev"},{"key":"244_CR65","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nature02661","volume":"429","author":"T Lu","year":"2004","unstructured":"Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883\u2013891 (2004).","journal-title":"Nature"},{"key":"244_CR66","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman, S., Izzy, S., Sen, P., Morsett, L. & El Khoury, J. Microglia in neurodegeneration. Nat. Neurosci. 21, 1359\u20131369 (2018).","journal-title":"Nat. Neurosci."},{"key":"244_CR67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.22350","volume":"61","author":"C Cunningham","year":"2013","unstructured":"Cunningham, C. Microglia and neurodegeneration: the role of systemic inflammation. Glia 61, 71\u201390 (2013).","journal-title":"Glia"},{"key":"244_CR68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","volume":"18","author":"YH Youm","year":"2013","unstructured":"Youm, Y. H. et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 18, 519\u2013532 (2013).","journal-title":"Cell Metab."},{"key":"244_CR69","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat.\u00a0Immunol. 9, 857\u2013865 (2008).","journal-title":"Nat. Immunol."},{"key":"244_CR70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo, G. et al. Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS One 8, e55375 (2013).","journal-title":"PLoS One"},{"key":"244_CR71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","volume":"399","author":"VO Ona","year":"1999","unstructured":"Ona, V. O. et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington\u2019s disease. Nature 399, 263\u2013267 (1999).","journal-title":"Nature"},{"key":"244_CR72","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","volume":"63","author":"S Johann","year":"2015","unstructured":"Johann, S. et al. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63, 2260\u20132273 (2015).","journal-title":"Glia"},{"key":"244_CR73","doi-asserted-by":"crossref","first-page":"13046","DOI":"10.1073\/pnas.1002396107","volume":"107","author":"F Meissner","year":"2010","unstructured":"Meissner, F., Molawi, K. & Zychlinsky, A. Mutant superoxide dismutase 1-induced IL-1\u03b2 accelerates ALS pathogenesis. Proc. Natl Acad. Sci. USA 107, 13046\u201313050 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"244_CR74","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang, W. Y., Tan, M. S., Yu, J. T. & Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann. Transl Med. 3, 136 (2015).","journal-title":"Ann Transl Med"},{"key":"244_CR75","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","volume":"113","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein \u03b1-synuclein. Proc. Natl Acad. Sci. USA 113, 9587\u20139592 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"244_CR76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yfrne.2016.09.001","volume":"43","author":"MF Uchoa","year":"2016","unstructured":"Uchoa, M. F., Moser, V. A. & Pike, C. J. Interactions between inflammation, sex steroids, and Alzheimer\u2019s disease risk factors. Front. Neuroendocrinol. 43, 60\u201382 (2016).","journal-title":"Front. Neuroendocrinol."},{"key":"244_CR77","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.biocel.2004.04.020","volume":"36","author":"T Grune","year":"2004","unstructured":"Grune, T., Jung, T., Merker, K. & Davies, K. J. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and \u2018aggresomes\u2019 during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol. 36, 2519\u20132530 (2004).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"244_CR78","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222\u2013230 (2011).","journal-title":"Nat. Immunol."},{"key":"244_CR79","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI95145","volume":"128","author":"DJ Baker","year":"2018","unstructured":"Baker, D. J. & Petersen, R. C. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J. Clin. Invest. 128, 1208\u20131216 (2018).","journal-title":"J. Clin. Invest."},{"key":"244_CR80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/ijms17050685","volume":"17","author":"MR Pan","year":"2016","unstructured":"Pan, M. R., Li, K., Lin, S. Y. & Hung, W. C. Connecting the dots: from DNA damage and repair to aging. Int. J. Mol. Sci. 17, 685 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"244_CR81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10522-015-9578-8","volume":"17","author":"D Frasca","year":"2016","unstructured":"Frasca, D. & Blomberg, B. B. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology 17, 7\u201319 (2016).","journal-title":"Biogerontology"},{"key":"244_CR82","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2017.12.015","volume":"105","author":"A Bektas","year":"2018","unstructured":"Bektas, A., Schurman, S. H., Sen, R. & Ferrucci, L. Aging, inflammation and the environment. Exp. Gerontol. 105, 10\u201318 (2018).","journal-title":"Exp. Gerontol."},{"key":"244_CR83","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40478-016-0409-1","volume":"5","author":"E Valera","year":"2017","unstructured":"Valera, E. et al. Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy. Acta Neuropathol. Commun. 5, 2 (2017).","journal-title":"Acta Neuropathol Commun"},{"key":"244_CR84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J. et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537, 50\u201356 (2016).","journal-title":"Nature"},{"key":"244_CR85","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00335-016-9647-6","volume":"27","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe, C., Vandendriessche, C., Libert, C. & Vandenbroucke, R. E. Caloric restriction: beneficial effects on brain aging and Alzheimer\u2019s disease. Mamm. Genome 27, 300\u2013319 (2016).","journal-title":"Mamm. Genome"},{"key":"244_CR86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainresbull.2016.03.012","volume":"125","author":"LJ Spielman","year":"2016","unstructured":"Spielman, L. J., Little, J. P. & Klegeris, A. Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Res. Bull. 125, 19\u201329 (2016).","journal-title":"Brain Res. Bull."},{"key":"244_CR87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris, L. M., Yu, C. E., Bird, T. D. & Tsuang, D. W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 23, 213\u2013227 (2010).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"244_CR88","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"244_CR89","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505\u2013508 (2014).","journal-title":"JAMA Neurol"},{"key":"244_CR90","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang, J., Gu, B. J., Masters, C. L. & Wang, Y. J. A systemic view of Alzheimer disease \u2013 insights from amyloid-\u03b2 metabolism beyond the brain. Nat. Rev. Neurol. 13, 612\u2013623 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"244_CR91","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane, C. A., Hardy, J. & Schott, J. M. Alzheimer\u2019s disease. Eur. J. Neurol. 25, 59\u201370 (2018).","journal-title":"Eur. J. Neurol."},{"key":"244_CR92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"244_CR93","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini, M. G. & Goedert, M. Tau pathology and neurodegeneration. Lancet Neurol. 12, 609\u2013622 (2013).","journal-title":"Lancet Neurol."},{"key":"244_CR94","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1021\/acschemneuro.8b00402","volume":"10","author":"WY Fu","year":"2019","unstructured":"Fu, W. Y., Wang, X. & Ip, N. Y. Targeting neuroinflammation as a therapeutic strategy for Alzheimer\u2019s disease: mechanisms, drug candidates, and new opportunities. ACS Chem. Neurosci. 10, 872\u2013879 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"244_CR95","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","volume":"110","author":"J Hardy","year":"2009","unstructured":"Hardy, J. The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal. J. Neurochem. 110, 1129\u20131134 (2009).","journal-title":"J. Neurochem."},{"key":"244_CR96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","volume":"88","author":"AM Hall","year":"2012","unstructured":"Hall, A. M. & Roberson, E. D. Mouse models of Alzheimer\u2019s disease. Brain Res. Bull. 88, 3\u201312 (2012).","journal-title":"Brain Res. Bull."},{"key":"244_CR97","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00429-009-0235-3","volume":"214","author":"CY Ewald","year":"2010","unstructured":"Ewald, C. Y. & Li, C. Understanding the molecular basis of Alzheimer\u2019s disease using a Caenorhabditis elegans model system. Brain Struct. Funct. 214, 263\u2013283 (2010).","journal-title":"Brain Struct Funct"},{"key":"244_CR98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-8-35","volume":"8","author":"K Prussing","year":"2013","unstructured":"Prussing, K., Voigt, A. & Schulz, J. B. Drosophila melanogaster as a model organism for Alzheimer\u2019s disease. Mol. Neurodegener. 8, 35 (2013).","journal-title":"Mol. Neurodegener."},{"key":"244_CR99","first-page":"6","volume":"24","author":"FHP Tan","year":"2017","unstructured":"Tan, F. H. P. & Azzam, G. Drosophila melanogaster: deciphering Alzheimer\u2019s disease. Malays. J. Med. Sci. 24, 6\u201320 (2017).","journal-title":"Malays. J. Med. Sci."},{"key":"244_CR100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-017-0268-4","volume":"9","author":"C Arber","year":"2017","unstructured":"Arber, C., Lovejoy, C. & Wray, S. Stem cell models of\u00a0Alzheimer\u2019s disease: progress and challenges. Alzheimers Res. Ther. 9, 42 (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"244_CR101","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.nbd.2015.09.002","volume":"82","author":"E Teng","year":"2015","unstructured":"Teng, E. et al. Dietary DHA supplementation in an APP\/PS1 transgenic rat model of AD reduces behavioral and A\u03b2 pathology and modulates A\u03b2 oligomerization. Neurobiol. Dis. 82, 552\u2013560 (2015).","journal-title":"Neurobiol. Dis."},{"key":"244_CR102","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1471-4159.1999.0720771.x","volume":"72","author":"MA Lovell","year":"1999","unstructured":"Lovell, M. A., Gabbita, S. P. & Markesbery, W. R. Increased DNA oxidation and decreased levels of repair products in Alzheimer\u2019s disease ventricular CSF. J. Neurochem. 72, 771\u2013776 (1999).","journal-title":"J. Neurochem."},{"key":"244_CR103","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1093\/nar\/gkm605","volume":"35","author":"L Weissman","year":"2007","unstructured":"Weissman, L. et al. Defective DNA base excision repair in brain from individuals with Alzheimer\u2019s disease and amnestic mild cognitive impairment. Nucleic Acids Res. 35, 5545\u20135555 (2007).","journal-title":"Nucleic Acids Res."},{"key":"244_CR104","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/nar\/gku1356","volume":"43","author":"P Sykora","year":"2015","unstructured":"Sykora, P. et al. DNA polymerase \u03b2 deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res. 43, 943\u2013959 (2015).","journal-title":"Nucleic Acids Res."},{"key":"244_CR105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12035-014-9015-z","volume":"53","author":"HZ Wang","year":"2016","unstructured":"Wang, H. Z. et al. Validating GWAS-identified risk loci for Alzheimer\u2019s disease in Han Chinese populations. Mol. Neurobiol. 53, 379\u2013390 (2016).","journal-title":"Mol. Neurobiol."},{"key":"244_CR106","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cmet.2016.09.004","volume":"24","author":"EF Fang","year":"2016","unstructured":"Fang, E. F. et al. NAD(+) replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 24, 566\u2013581 (2016).","journal-title":"Cell Metab."},{"key":"244_CR107","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","volume":"115","author":"Y Hou","year":"2018","unstructured":"Hou, Y. et al. NAD(+) supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc. Natl Acad. Sci. USA 115, E1876\u2013E1885 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"244_CR108","doi-asserted-by":"crossref","first-page":"783","DOI":"10.14348\/molcells.2016.0233","volume":"39","author":"MJ Kwon","year":"2016","unstructured":"Kwon, M. J., Kim, S., Han, M. H. & Lee, S. B. Epigenetic changes in neurodegenerative diseases. Mol. Cells 39, 783\u2013789 (2016).","journal-title":"Mol. Cells"},{"key":"244_CR109","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/pro.2524","volume":"23","author":"SY Ow","year":"2014","unstructured":"Ow, S. Y. & Dunstan, D. E. A brief overview of amyloids and Alzheimer\u2019s disease. Protein Sci. 23, 1315\u20131331 (2014).","journal-title":"Protein Sci."},{"key":"244_CR110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","volume":"40","author":"JS Kerr","year":"2017","unstructured":"Kerr, J. S. et al. Mitophagy and Alzheimer\u2019s disease: cellular and molecular mechanisms. Trends Neurosci. 40, 151\u2013166 (2017).","journal-title":"Trends Neurosci."},{"key":"244_CR111","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang, E. F. et al. Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat. Neurosci. 22, 401\u2013412 (2019).","journal-title":"Nat. Neurosci."},{"key":"244_CR112","volume":"7","author":"R Bhat","year":"2012","unstructured":"Bhat, R. et al. Astrocyte senescence as a component of Alzheimer\u2019s disease. PLoS One 7, e45069 (2012).","journal-title":"PLoS One"},{"key":"244_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2015.04.003","volume":"22","author":"V Boccardi","year":"2015","unstructured":"Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C. & Mecocci, P. From cellular senescence to Alzheimer\u2019s disease: the role of telomere shortening. Ageing Res. Rev. 22, 1\u20138 (2015).","journal-title":"Ageing Res Rev"},{"key":"244_CR114","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.celrep.2017.12.092","volume":"22","author":"SJ Chinta","year":"2018","unstructured":"Chinta, S. J. et al. Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson\u2019s disease. Cell Rep 22, 930\u2013940 (2018).","journal-title":"Cell Rep"},{"key":"244_CR115","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/cdd.2016.37","volume":"23","author":"C Turnquist","year":"2016","unstructured":"Turnquist, C. et al. p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death Differ. 23, 1515\u20131528 (2016).","journal-title":"Cell Death Differ."},{"key":"244_CR116","volume":"4","author":"N He","year":"2013","unstructured":"He, N. et al. Amyloid-\u03b2(1-42) oligomer accelerates senescence in adult hippocampal neural stem\/progenitor cells via formylpeptide receptor 2. Cell\u00a0Death Dis. 4, e924 (2013).","journal-title":"Cell Death Dis."},{"key":"244_CR117","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","volume":"21","author":"JL Kirkland","year":"2017","unstructured":"Kirkland, J. L. & Tchkonia, T. Cellular senescence: a translational perspective. EBioMedicine 21, 21\u201328 (2017).","journal-title":"EBioMedicine"},{"key":"244_CR118","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582 (2018).","journal-title":"Nature"},{"key":"244_CR119","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat. Neurosci. 22, 719\u2013728 (2019).","journal-title":"Nat. Neurosci."},{"key":"244_CR120","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12840","volume":"17","author":"N Musi","year":"2018","unstructured":"Musi, N. et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17, e12840 (2018).","journal-title":"Aging Cell"},{"key":"244_CR121","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot, K. et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316\u20131338 (2012).","journal-title":"J. Clin. Invest."},{"key":"244_CR122","first-page":"941","volume-title":"Front Biosci (Schol Ed)","author":"S Oddo","year":"2012","unstructured":"Oddo, S. The role of mTOR signaling in Alzheimer disease. Front. Biosci. (Schol Ed) 4, 941\u2013952 (2012)."},{"key":"244_CR123","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07331.x","volume":"118","author":"A Salminen","year":"2011","unstructured":"Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H. & Hiltunen, M. AMP-activated protein kinase: a potential player in Alzheimer\u2019s disease. J.\u00a0Neurochem. 118, 460\u2013474 (2011).","journal-title":"J. Neurochem."},{"key":"244_CR124","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola, S. & Mattson, M. P. Brain metabolism in health, aging, and neurodegeneration. EMBO J. 36, 1474\u20131492 (2017).","journal-title":"EMBO J."},{"key":"244_CR125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnagi.2015.00094","volume":"7","author":"FG De Felice","year":"2015","unstructured":"De Felice, F. G. & Lourenco, M. V. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer\u2019s disease. Front. Aging Neurosci. 7, 94 (2015).","journal-title":"Front. Aging Neurosci."},{"key":"244_CR126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/156720512799015064","volume":"9","author":"H Cai","year":"2012","unstructured":"Cai, H. et al. Metabolic dysfunction in Alzheimer\u2019s disease and related neurodegenerative disorders. Curr. Alzheimer Res. 9, 5\u201317 (2012).","journal-title":"Curr Alzheimer Res"},{"key":"244_CR127","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","volume":"95","author":"M Simons","year":"1998","unstructured":"Simons, M. et al. Cholesterol depletion inhibits the generation of \u03b2-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95, 6460\u20136464 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"244_CR128","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2174\/1568026615666150610141524","volume":"15","author":"C Vivar","year":"2015","unstructured":"Vivar, C. Adult hippocampal neurogenesis, aging and neurodegenerative diseases: possible strategies to prevent cognitive impairment. Curr. Top. Med. Chem. 15, 2175\u20132192 (2015).","journal-title":"Curr. Top. Med. Chem."},{"key":"244_CR129","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","volume":"31","author":"PL McClean","year":"2011","unstructured":"McClean, P. L., Parthsarathy, V., Faivre, E. & Holscher, C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer\u2019s disease. J. Neurosci. 31, 6587\u20136594 (2011).","journal-title":"J. Neurosci."},{"key":"244_CR130","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","volume":"18","author":"L Ho","year":"2004","unstructured":"Ho, L. et al. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease. FASEB J. 18, 902\u2013904 (2004).","journal-title":"FASEB J."},{"key":"244_CR131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41531-016-0001-1","volume":"3","author":"Y Takamatsu","year":"2017","unstructured":"Takamatsu, Y. et al. Combined immunotherapy with \u201canti-insulin resistance\u201d therapy as a novel therapeutic strategy against neurodegenerative diseases. NPJ\u00a0Parkinsons Dis. 3, 4 (2017).","journal-title":"NPJ Parkinsons Dis"},{"key":"244_CR132","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157015911798376325","volume":"9","author":"MT Heneka","year":"2011","unstructured":"Heneka, M. T., Reyes-Irisarri, E., Hull, M. & Kummer, M. P. Impact and therapeutic potential of PPARs in Alzheimer\u2019s disease. Curr. Neuropharmacol. 9, 643\u2013650 (2011).","journal-title":"Curr. Neuropharmacol."},{"key":"244_CR133","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fendo.2018.00400","volume":"9","author":"C Rotermund","year":"2018","unstructured":"Rotermund, C., Machetanz, G. & Fitzgerald, J. C. The therapeutic potential of metformin in neurodegenerative diseases. Front. Endocrinol. 9, 400 (2018).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"244_CR134","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus, H. & Heneka, M. T. Microglia in Alzheimer\u2019s disease. J. Clin. Invest. 127, 3240\u20133249 (2017).","journal-title":"J. Clin. Invest."},{"key":"244_CR135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JPD-150543","volume":"5","author":"R Melki","year":"2015","unstructured":"Melki, R. Role of different alpha-synuclein strains in\u00a0synucleinopathies, similarities with other neurodegenerative diseases. J. Parkinsons Dis. 5, 217\u2013227 (2015).","journal-title":"J. Parkinsons Dis."},{"key":"244_CR136","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha, E. M., De Miranda, B. & Sanders, L. H. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol. Dis. 109, 249\u2013257 (2018).","journal-title":"Neurobiol. Dis."},{"key":"244_CR137","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson\u2019s disease. J. Parkinsons Dis. 3, 461\u2013491 (2013).","journal-title":"J. Parkinsons Dis."},{"key":"244_CR138","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch, E. C. & Hunot, S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 8, 382\u2013397 (2009).","journal-title":"Lancet Neurol."},{"key":"244_CR139","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.celrep.2016.04.071","volume":"15","author":"S Sepe","year":"2016","unstructured":"Sepe, S. et al. Inefficient DNA repair is an aging-related modifier of Parkinson\u2019s disease. Cell Rep. 15, 1866\u20131875 (2016).","journal-title":"Cell Rep"},{"key":"244_CR140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-016-1590-9","volume":"132","author":"C Labbe","year":"2016","unstructured":"Labbe, C., Lorenzo-Betancor, O. & Ross, O. A. Epigenetic regulation in Parkinson\u2019s disease. Acta Neuropathol. 132, 515\u2013530 (2016).","journal-title":"Acta Neuropathol."},{"key":"244_CR141","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JPD-171296","volume":"8","author":"DW Curry","year":"2018","unstructured":"Curry, D. W., Stutz, B., Andrews, Z. B. & Elsworth, J. D. Targeting AMPK signaling as a neuroprotective strategy in Parkinson\u2019s disease. J. Parkinsons Dis. 8, 161\u2013181 (2018).","journal-title":"J. Parkinsons Dis."},{"key":"244_CR142","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu, I. & Bennett, S. A. L. Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease. Front. Neurosci. 13, 328 (2019).","journal-title":"Front. Neurosci."},{"key":"244_CR143","doi-asserted-by":"crossref","first-page":"454696","DOI":"10.1155\/2014\/454696","volume":"2014","author":"M Regensburger","year":"2014","unstructured":"Regensburger, M., Prots, I. & Winner, B. Adult hippocampal neurogenesis in Parkinson\u2019s disease: impact on neuronal survival and plasticity. Neural Plast. 2014, 454696 (2014).","journal-title":"Neural Plast."},{"key":"244_CR144","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi, T. et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature 548, 592\u2013596 (2017).","journal-title":"Nature"},{"key":"244_CR145","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38, 1285\u20131291 (1988).","journal-title":"Neurology"},{"key":"244_CR146","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.embor.7400210","volume":"5","author":"PJ McKinnon","year":"2004","unstructured":"McKinnon, P. J. ATM and ataxia telangiectasia. EMBO Rep. 5, 772\u2013776 (2004).","journal-title":"EMBO Rep"},{"key":"244_CR147","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nn1648","volume":"9","author":"JT Walter","year":"2006","unstructured":"Walter, J. T., Alvina, K., Womack, M. D., Chevez, C. & Khodakhah, K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat. Neurosci. 9, 389\u2013397 (2006).","journal-title":"Nat. Neurosci."},{"key":"244_CR148","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2011-08-373639","volume":"119","author":"YA Valentin-Vega","year":"2012","unstructured":"Valentin-Vega, Y. A. et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 119, 1490\u20131500 (2012).","journal-title":"Blood"},{"key":"244_CR149","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.1192912","volume":"330","author":"Z Guo","year":"2010","unstructured":"Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D. & Paull, T. T. ATM activation by oxidative stress. Science 330, 517\u2013521 (2010).","journal-title":"Science"},{"key":"244_CR150","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers 3, 17071 (2017).","journal-title":"Nat Rev Dis Primers"},{"key":"244_CR151","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis.\u00a0Primers 1, 15005 (2015).","journal-title":"Nat Rev Dis Primers"},{"key":"244_CR152","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.arr.2016.08.002","volume":"33","author":"AC Karikkineth","year":"2017","unstructured":"Karikkineth, A. C., Scheibye-Knudsen, M., Fivenson, E., Croteau, D. L. & Bohr, V. A. Cockayne syndrome: clinical features, model systems and pathways. Ageing Res. Rev. 33, 3\u201317 (2017).","journal-title":"Ageing Res Rev"},{"key":"244_CR153","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/1673-5374.226377","volume":"13","author":"D Penndorf","year":"2018","unstructured":"Penndorf, D., Witte, O. W. & Kretz, A. DNA plasticity and damage in amyotrophic lateral sclerosis. Neural Regen. Res. 13, 173\u2013180 (2018).","journal-title":"Neural Regen Res"},{"key":"244_CR154","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12017-012-8207-9","volume":"15","author":"Z Cai","year":"2013","unstructured":"Cai, Z., Yan, L. J. & Ratka, A. Telomere shortening and Alzheimer\u2019s disease. Neuromol. Med. 15, 25\u201348 (2013).","journal-title":"Neuromolecular Med."},{"key":"244_CR155","doi-asserted-by":"crossref","first-page":"382","DOI":"10.18632\/aging.100904","volume":"8","author":"B Linkus","year":"2016","unstructured":"Linkus, B. et al. Telomere shortening leads to earlier age of onset in ALS mice. Aging 8, 382\u2013393 (2016).","journal-title":"Aging (Albany NY)"},{"key":"244_CR156","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1176\/appi.neuropsych.13100240","volume":"27","author":"LN Kota","year":"2015","unstructured":"Kota, L. N. et al. Reduced telomere length in neurodegenerative disorders may suggest shared biology. J. Neuropsychiatry Clin. Neurosci. 27, e92\u2013e96 (2015).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"244_CR157","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","volume":"4","author":"RC Block","year":"2010","unstructured":"Block, R. C., Dorsey, E. R., Beck, C. A., Brenna, J. T. &\u00a0Shoulson, I. Altered cholesterol and fatty acid metabolism in Huntington disease. J. Clin. Lipidol. 4, 17\u201323 (2010).","journal-title":"J. Clin. Lipidol."},{"key":"244_CR158","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1101\/gad.869001","volume":"15","author":"DM Allen","year":"2001","unstructured":"Allen, D. M. et al. Ataxia telangiectasia mutated is essential during adult neurogenesis. Genes Dev. 15, 554\u2013566 (2001).","journal-title":"Genes Dev."},{"key":"244_CR159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000029","volume":"6","author":"N Amariglio","year":"2009","unstructured":"Amariglio, N. et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 6, e1000029 (2009).","journal-title":"PLoS Med."},{"key":"244_CR160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp, E. et al. Early and progressive accumulation of\u00a0reactive microglia in the Huntington disease brain. J.\u00a0Neuropathol. Exp. Neurol. 60, 161\u2013172 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"244_CR161","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel, J. S. et al. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55, 221\u2013235 (2004).","journal-title":"Ann. Neurol."},{"key":"244_CR162","volume":"15","author":"CW Hui","year":"2018","unstructured":"Hui, C. W., Song, X., Ma, F., Shen, X. & Herrup, K. Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice. J.\u00a0Neuroinflammation 15, 308 (2018).","journal-title":"J. Neuroinflammation"},{"key":"244_CR163","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1083\/jcb.201806197","volume":"218","author":"HM Chow","year":"2019","unstructured":"Chow, H. M. et al. ATM is activated by ATP depletion and modulates mitochondrial function through NRF1. J. Cell Biol. 218, 909\u2013928 (2019).","journal-title":"J. Cell Biol."},{"key":"244_CR164","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13024-016-0127-y","volume":"11","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment. Mol. Neurodegener. 11, 60 (2016).","journal-title":"Mol. Neurodegener."},{"key":"244_CR165","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12948","volume":"7","author":"SA Trammell","year":"2016","unstructured":"Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).","journal-title":"Nat Commun"},{"key":"244_CR166","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.aaf2693","volume":"352","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352, 1436\u20131443 (2016).","journal-title":"Science"},{"key":"244_CR167","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","volume":"155","author":"AP Gomes","year":"2013","unstructured":"Gomes, A. P. et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624\u20131638 (2013).","journal-title":"Cell"},{"key":"244_CR168","doi-asserted-by":"crossref","first-page":"17010","DOI":"10.1073\/pnas.1213956109","volume":"109","author":"H De Jesus-Cortes","year":"2012","unstructured":"De Jesus-Cortes, H. et al. Neuroprotective efficacy of\u00a0aminopropyl carbazoles in a mouse model of Parkinson disease. Proc. Natl Acad. Sci. USA 109, 17010\u201317015 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"244_CR169","doi-asserted-by":"crossref","first-page":"021","DOI":"10.23937\/2469-5858\/1510021","volume":"3","author":"MJ Phelan","year":"2017","unstructured":"Phelan, M. J., Mulnard, R. A., Gillen, D. L. & Schreiber, S. S. Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer\u2019s disease. J. Geriatr. Med. Gerontol. 3, 021 (2017).","journal-title":"J Geriatr Med Gerontol"},{"key":"244_CR170","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm.4132","volume":"22","author":"D Ryu","year":"2016","unstructured":"Ryu, D. et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22, 879\u2013888 (2016).","journal-title":"Nat. Med."},{"key":"244_CR171","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nchembio.2287","volume":"13","author":"ND Georgakopoulos","year":"2017","unstructured":"Georgakopoulos, N. D., Wells, G. & Campanella, M. The pharmacological regulation of cellular mitophagy. Nat. Chem. Biol. 13, 136\u2013146 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"244_CR172","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/biof.118","volume":"36","author":"D Albani","year":"2010","unstructured":"Albani, D., Polito, L., Signorini, A. & Forloni, G. Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36, 370\u2013376 (2010).","journal-title":"Biofactors"},{"key":"244_CR173","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.fct.2017.07.050","volume":"108","author":"J Heilman","year":"2017","unstructured":"Heilman, J., Andreux, P., Tran, N., Rinsch, C. & Blanco-Bose, W. Safety assessment of urolithin A, a\u00a0metabolite produced by the human gut microbiota upon dietary intake of plant derived ellagitannins andellagic acid. Food Chem. Toxicol. 108, 289\u2013297 (2017).","journal-title":"Food Chem. Toxicol."},{"key":"244_CR174","doi-asserted-by":"crossref","first-page":"2012798","DOI":"10.1155\/2017\/2012798","volume":"2017","author":"OC Moreira","year":"2017","unstructured":"Moreira, O. C. et al. Mitochondrial function and mitophagy in the elderly: effects of exercise. Oxid.\u00a0Med. Cell. Longev. 2017, 2012798 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"244_CR175","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb3225","volume":"17","author":"N Herranz","year":"2015","unstructured":"Herranz, N. et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17, 1205\u20131217 (2015).","journal-title":"Nat. Cell Biol."},{"key":"244_CR176","doi-asserted-by":"crossref","first-page":"231","DOI":"10.18632\/aging.100872","volume":"8","author":"HE Walters","year":"2016","unstructured":"Walters, H. E., Deneka-Hannemann, S. & Cox, L. S. Reversal of phenotypes of cellular senescence by pan-mTOR inhibition. Aging 8, 231\u2013244 (2016).","journal-title":"Aging (Albany NY)"},{"key":"244_CR177","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","volume":"125","author":"N Katila","year":"2017","unstructured":"Katila, N. et al. Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology 125, 396\u2013407 (2017).","journal-title":"Neuropharmacology"},{"key":"244_CR178","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","volume":"69","author":"Z Ou","year":"2018","unstructured":"Ou, Z. et al. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice. Brain. Behav. Immun. 69, 351\u2013363 (2018).","journal-title":"Brain. Behav. Immun."},{"key":"244_CR179","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/clpt.2012.193","volume":"93","author":"RM Naylor","year":"2013","unstructured":"Naylor, R. M., Baker, D. J. & van Deursen, J. M. Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin. Pharmacol. Ther. 93, 105\u2013116 (2013).","journal-title":"Clin. Pharmacol. Ther."},{"key":"244_CR180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cell.2017.03.014","volume":"169","author":"P Krimpenfort","year":"2017","unstructured":"Krimpenfort, P. & Berns, A. Rejuvenation by therapeutic elimination of senescent cells. Cell 169, 3\u20135 (2017).","journal-title":"Cell"},{"key":"244_CR181","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem"},{"key":"244_CR182","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement"},{"key":"244_CR183","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3390\/ijms19041160","volume":"19","author":"M Medina","year":"2018","unstructured":"Medina, M. An overview on the clinical development of tau-based therapeutics. Int. J. Mol. Sci. 19, 1160 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"244_CR184","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0404.1996.tb05866.x","volume":"165","author":"H Braak","year":"1996","unstructured":"Braak, H. & Braak, E. Evolution of the neuropathology of Alzheimer\u2019s disease. Acta Neurol. Scand. Suppl. 165, 3\u201312 (1996).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"244_CR185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","volume":"4","author":"J Cummings","year":"2018","unstructured":"Cummings, J., Lee, G., Ritter, A. & Zhong, K. Alzheimer\u2019s disease drug development pipeline: 2018. Alzheimers Dement. 4, 195\u2013214 (2018).","journal-title":"Alzheimers Dement (N Y)"},{"key":"244_CR186","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/dom.13373","volume":"20","author":"B Cao","year":"2018","unstructured":"Cao, B. et al. Comparative efficacy and acceptability of\u00a0antidiabetic agents for Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and network meta-analysis. Diabetes Obes. Metab. 20, 2467\u20132471 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"244_CR187","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40266-015-0239-z","volume":"32","author":"M Miguel-Alvarez","year":"2015","unstructured":"Miguel-Alvarez, M. et al. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer\u2019s disease: a systematic review and meta-analysis of treatment effect. Drugs Aging 32, 139\u2013147 (2015).","journal-title":"Drugs Aging"},{"key":"244_CR188","first-page":"CD008454","volume":"9","author":"K Rees","year":"2011","unstructured":"Rees, K. et al. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson\u2019s disease: evidence from observational studies. Cochrane Database of Systematic Reviews 9, CD008454 (2011).","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"244_CR189","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02588677 (2018)."},{"key":"244_CR190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","volume":"9","author":"D Petrov","year":"2017","unstructured":"Petrov, D., Mansfield, C., Moussy, A. & Hermine, O. ALS clinical trials review: 20 years of failure. are we any closer to registering a new treatment? Front. Aging Neurosci. 9, 68 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"244_CR191","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.arr.2016.08.004","volume":"31","author":"AM Vaiserman","year":"2016","unstructured":"Vaiserman, A. M., Lushchak, O. V. & Koliada, A. K. Anti-aging pharmacology: promises and pitfalls. Ageing Res. Rev. 31, 9\u201335 (2016).","journal-title":"Ageing Res Rev"},{"key":"244_CR192","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fphys.2018.00044","volume":"9","author":"JD Hernandez-Camacho","year":"2018","unstructured":"Hernandez-Camacho, J. D., Bernier, M., Lopez-Lluch, G. & Navas, P. Coenzyme Q10 supplementation in aging and disease. Front. Physiol. 9, 44 (2018).","journal-title":"Front. Physiol."},{"key":"244_CR193","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.20180139","volume":"215","author":"T Li","year":"2018","unstructured":"Li, T. & Chen, Z. J. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J. Exp. Med. 215, 1287\u20131299 (2018).","journal-title":"J. Exp. Med."},{"key":"244_CR194","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40478-014-0176-9","volume":"2","author":"R Giraldez-Perez","year":"2014","unstructured":"Giraldez-Perez, R., Antolin-Vallespin, M., Munoz, M. & Sanchez-Capelo, A. Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease. Acta Neuropathol. Commun. 2, 176 (2014).","journal-title":"Acta Neuropathol Commun"},{"key":"244_CR195","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz, C. & Mayeux, R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88, 640\u2013651 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"244_CR196","doi-asserted-by":"crossref","first-page":"S527","DOI":"10.3233\/JAD-2010-100501","volume":"20","author":"J Vina","year":"2010","unstructured":"Vina, J. & Lloret, A. Why women have more Alzheimer\u2019s disease than men: gender and mitochondrial toxicity of amyloid-\u03b2 peptide. J.\u00a0Alzheimers Dis. 20, S527\u2013S533 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"244_CR197","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","volume":"65","author":"JA Luchsinger","year":"2005","unstructured":"Luchsinger, J. A. et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545\u2013551 (2005).","journal-title":"Neurology"},{"key":"244_CR198","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-2002-4308","volume":"4","author":"WB Grant","year":"2002","unstructured":"Grant, W. B., Campbell, A., Itzhaki, R. F. & Savory, J. The significance of environmental factors in the etiology of Alzheimer\u2019s disease. J. Alzheimers Dis. 4, 179\u2013189 (2002).","journal-title":"J. Alzheimers Dis."},{"key":"244_CR199","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"244_CR200","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00019442-200510000-00003","volume":"13","author":"D Weintraub","year":"2005","unstructured":"Weintraub, D. & Stern, M. B. Psychiatric complications in Parkinson disease. Am. J. Geriatr. Psychiatry 13, 844\u2013851 (2005).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"244_CR201","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp-2013-305805","volume":"85","author":"E Mak","year":"2014","unstructured":"Mak, E. et al. Cognitive deficits in mild Parkinson\u2019s disease are associated with distinct areas of grey matter atrophy. J. Neurol. Neurosurg. Psychiatry 85, 576\u2013580 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"244_CR202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/B978-0-12-802973-2.00013-6","volume":"138","author":"EO Talbott","year":"2016","unstructured":"Talbott, E. O., Malek, A. M. & Lacomis, D. The\u00a0epidemiology of amyotrophic lateral sclerosis. Handb.\u00a0Clin. Neurol. 138, 225\u2013238 (2016).","journal-title":"Handb. Clin. Neurol."},{"key":"244_CR203","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker, F. O. Huntington\u2019s disease. Lancet 369, 218\u2013228 (2007).","journal-title":"Lancet"},{"key":"244_CR204","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1172871","volume":"324","author":"S Subramaniam","year":"2009","unstructured":"Subramaniam, S., Sixt, K. M., Barrow, R. & Snyder, S. H. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327\u20131330 (2009).","journal-title":"Science"},{"key":"244_CR205","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff, K. et al. Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the Predict-HD study. Biol.\u00a0Psychiatry 62, 1341\u20131346 (2007).","journal-title":"Biol. Psychiatry"},{"key":"244_CR206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/alzrt251","volume":"6","author":"YR Zweig","year":"2014","unstructured":"Zweig, Y. R. & Galvin, J. E. Lewy body dementia: the\u00a0impact on patients and caregivers. Alzheimers Res.\u00a0Ther. 6, 21 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"244_CR207","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt, C. et al. Ataxia telangiectasia: a review. Orphanet J. Rare Dis. 11, 159 (2016).","journal-title":"Orphanet J. Rare Dis."},{"key":"244_CR208","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.dnarep.2008.01.014","volume":"7","author":"WJ Kleijer","year":"2008","unstructured":"Kleijer, W. J. et al. Incidence of DNA repair deficiency disorders in western Europe: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA\u00a0Repair 7, 744\u2013750 (2008).","journal-title":"DNA Repair (Amst)"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41582-019-0244-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41582-019-0244-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41582-019-0244-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:11:50Z","timestamp":1684606310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-019-0244-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":208,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1038\/s41582-019-0244-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736582761.793568228","asserted-by":"object"}]},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]},"assertion":[{"value":"12 July 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}